BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Maryland Psychiatric Society - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mdpsych.org
X-WR-CALDESC:Events for Maryland Psychiatric Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181117T083000
DTEND;TZID=America/New_York:20181117T163000
DTSTAMP:20181102T165809Z
CREATED:20181102T142350Z
LAST-MODIFIED:20181102T165809Z
UID:2992-1542443400-1542472200@mdpsych.org
SUMMARY:Maryland Psychiatric Society  Psychopharmacology Symposium
DESCRIPTION:PURCHASE MEMBER TICKETS HERE \n  \nPURCHASE NON-MEMBER TICKETS HERE \n  \n  \nAGENDA:  \n8:30AM\nBreakfast and Registration \n9:00AM\nHypnotics: David Neubauer\, M.D. \n10:00AM\nMedical Cannabis and Cannabis Use Disorders: George Kolodner\, M.D. & Sunil Khushalani\, M.D. \n11:00AM\nBreak \n11:15AM\nOptimizing Safe and Evidence-based Medication Treatment of Children & Adolescents: Gloria Reeves\, M.D. \n12:15PM\nLunch (Provided) \n1:15PM\nUpdate on the Psychopharmacology of Opioid Use Disorders: George Kolodner\, M.D. & Sunil Khushalani\, M.D. \n2:15PM\nPharmacogenomic Testing for Psychiatrists: An Introduction: Francis Mondimore\, M.D. \n3:15PM\nBreak \n3:30PM\nUpdate on the Psychopharmacology of Alcohol Use Disorders: George Kolodner\, M.D. & Sunil Khushalani\, M.D. \n  \nSPEAKERS: \nDavid N. Neubauer\, MD\, is an Associate Professor of Psychiatry at the Johns Hopkins University School of Medicine and Associate Director of the Johns Hopkins Sleep Disorders Center. He is a Fellow of the American Academy of Sleep Medicine and Life Fellow of the American Psychiatric Association. He is a member of the Sleep Research Society. He has written numerous journal articles and book chapters on sleep related topics. Dr. Neubauer was appointed by the American Psychiatric Association as liaison to the National Sleep Foundation Sleep Time Recommendations project. He currently serves on the National Sleep Foundation Board of Directors. \nGeorge Kolodner\, MD\, is an addiction psychiatrist who specializes in the outpatient treatment of substance use disorders. After leaving the Navy in 1973\, he designed and implemented the first intensive outpatient addiction treatment program in the country – Kolmac Outpatient Recovery Centers – where he continues to serve as the medical director. \nSunil Khushalani\, MD\, is an addiction psychiatrist who specializes in treating patients who suffer from co-occurring psychiatric and addiction issues. Dr. Khushalani serves as the service chief of the Co-Occurring Disorders unit and the Adult Day Hospital at  Sheppard Pratt. The co-occurring disorders program offers an integrated approach that treats both the addiction and mental health issues simultaneously. \nGloria Reeves\, MD\, is a child and adolescent psychiatrist at The University of Maryland. Dr. Reeves partnered with pharmacists\, child mental health experts\, and child-serving state agency leadership to help develop an antipsychotic medication prior authorization program for publicly-insured youth <18 years old.  She currently serves as Medical Director of this program\, and also serves as Medical Director of the Strive for Wellness program. \nFrancis Mondimore\, M.D. is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins and is the director of the Mood Disorders Clinic at the Johns Hopkins Bayview Medical Center. Here\, in conjunction with the National Network of Depression Centers\, the clinical and research team is investigating the longitudinal course of serious depression and bipolar disorder in order to determine what constitute “best practices” for the care of individuals with these illnesses. \n  \nGOALS/OBJECTIVES: \nAt the end of this educational activity\, the learner will be able to: \n\nReview key elements in evaluating insomnia\nDiscuss broad approaches to treating insomnia\nList four major categories of substances people take to promote sleep\nDescribe primary pharmacodynamic and pharmacokinetic properties of FDA-approved insomnia medications\nIncrease familiarity with the medical benefits and potential dangers of cannabis\nImprove ability to use medications in the treatment of opioid use disorders\nImprove ability to use medications in the treatment of alcohol use disorder\nBecome familiar with using pharmacogenomic testing to aid in selecting psychiatric medications\nReview current FDA approved indications for pediatric antipsychotic treatment and risk-to-benefit considerations in treatment with these medications in young patients\n\n 
URL:https://mdpsych.org/meetings/maryland-psychiatric-society-psychopharmacology-symposium/
LOCATION:Conference Center at Sheppard Pratt\, 6501 North Charles Street\, Towson\, MD\, 21204\, United States
ORGANIZER;CN="Maryland Psychiatric Society":MAILTO:mps@mdpsych.org
END:VEVENT
END:VCALENDAR